The recombination activating genes (RAGs) play a critical role in V(D)J recombination machinery and lymphocyte development. Their expression is strictly regulated during lymphocyte ontogeny, with expression being rapidly lost as the lymphoid precursors differentiate into their progeny. To elucidate molecular mechanisms of regulation of human RAG-1 gene expression, we examined a chromatin structure of a -24-kb DNA segment adjacent to a human RAG-I promoter region in various cell lines by analyzing DNase I hypersensitive (DNase I HS) sites. In a RAG-1-expressing human pre-B-cell line, at least four DNase I HS sites (HS1, HS2, HS3, and HS4) were identified. Among these HS sites, one HS site (HSI) was ubiquitously detected in all cell lines examined, but the other three HS sites (HS2, HS3, and HS4) were asso-HE VAST REPERTOIRE of Igs and T-cell receptors T (TCRs) is generated largely by a series of site-specific gene recombination events known as V(D)J recombination, which joins variable (V), diversity (D), and joining (J) gene segments of the Ig and TCR gene complexes.'-3 Two closely linked genes, recombination activating gene-1 (RAG-1) and RAG-2, that synergistically confer on fibroblasts the ability to specifically rearrange transfected V(D)J recombination substrates have been i~olated.~.' Recently, it has been shown that RAG-1 and RAG-2 products are sufficient to produce signal sequence-mediated double-strand breaks6,' RAG genes are specifically expressed in lymphoid cells in which the antigen receptor gene rearrangements are taking place. Their expression is developmentally regulated during lymphocyte differentiati~n?~.~-I~ Lymphoid progenitor cells in mice lacking either RAG-1 or RAG-2 genes could not rearrange their Ig or TCR genes, showing that RAG-1 and RAG-2 are essential to either activate or catalyze the V(D)J recombination reaction.'4-'6
T (TCRs) is generated largely by a series of site-specific gene recombination events known as V(D)J recombination, which joins variable (V), diversity (D), and joining (J) gene segments of the Ig and TCR gene complexes.'-3 Two closely linked genes, recombination activating gene-1 (RAG-1) and RAG-2, that synergistically confer on fibroblasts the ability to specifically rearrange transfected V(D)J recombination substrates have been i~olated.~.' Recently, it has been shown that RAG-1 and RAG-2 products are sufficient to produce signal sequence-mediated double-strand breaks6,' RAG genes are specifically expressed in lymphoid cells in which the antigen receptor gene rearrangements are taking place. Their expression is developmentally regulated during lymphocyte differentiati~n?~.~-I~ Lymphoid progenitor cells in mice lacking either RAG-1 or RAG-2 genes could not rearrange their Ig or TCR genes, showing that RAG-1 and RAG-2 are essential to either activate or catalyze the V(D)J recombination reaction.'4-' 6 We have been interested in delineating the signals and factors controlling the expression of human RAGs. We showed that RAG gene expression was induced in a human lymphoid progenitor cell line" by signals from a bone marrow-derived stromal cell line and recombinant cytokines, interleukin-3 (IL-3), IL-6, and IL-7. I8 We recently isolated human RAG-1 genomic clones and determined the organization of the gene. It was found that the human RAG-1 gene consists of two exons and one intron, as found in the murine counterpart. Regarding RAG-1 promoter, we have found that the promoter lacked a TATA box as well as an initiator sequence. Primer extension assay and RNase protection assay showed that the multiple RAG-1 transcription start sites clustered in a 31-nucleotide (nt) region.""
The structure of chromatin in the vicinity of a given gene is known to play a significant role in governing its correctly regulated expression. '920 DNase I hypersensitive (DNase I HS) sites within chromatin often correspond to sequences that play a critical role in activating transcription of the gene. In the present study, we have analyzed chromatin structure adjacent to a human RAG-1 promoter and evaluated the ability of the DNA segments containing these DNase I HS sites to have the transcriptional activity. Our data suggest ciated only with RAG-1 -expressing lymphoid cell lines. Using transient expression assays, we showed that the 5' upstream region of the major transcription start site showed low but significant promoter activity and that a DNA segment within HS3 located in the promoter region was indispensable to its basal promoter activity. Importantly, this promoter region was shown to be active in both RAG-1-expressing and RAG-1 -nonexpressing cell lines. These results suggest that alteration of chromatin structure in the promoter region, in addition to other control elements outside of the promoter region, is one of the mechanisms regulating tissue-and stage-specific expression of human RAG-1 gene.
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that alteration of a chromatin structure of the RAG-1 promoter region is responsible, at least in part, for the tissueand stage-specific expression of RAG-1 gene.
MATERIALS AND METHODS
Cell lines used in this study were Nalm6 (a human RAG-I+ pre-B-cell line), Jurkat (a human RAG-1' T-cell line), CEM (a human RAG-I+ T-cell line), Raji (a human RAG-1-B-cell line), RPMI-1788 (a human RAG-I-B-cell line), HUT78 (a human RAG-I-T-cell line), K562 (a human erythroid leukemic cell line), U937 (a human histiocytic lymphoma cell line), HeLa (a human cervical carcinoma cell line), and Hep3B (a human hepatoma cell line). Characteristics of these cell lines were previously described."." Nalm6, Jurkat, CEM, Raji, RPMI-1788, HUT78, U937, and KS62 cells were maintained in RPMI-1640 (GIBCO BRL, Grand Island, NY) containing 10% heat-inactivated fetal calf serum (JRH Biosciences, Lenexa, KS), 5 x m o m 2-mercaptoethanol (Wako Pure Chemical Industries, Osaka, Japan), 100 U/mL penicillin (Banyu Pharmaceutical Co, Tokyo, Japan), and 100 ,uglmL streptomycin (Meiji Seika Kaisa, Tokyo, Japan). HeLa and Hep3B cells were maintained in Dulbecco's modified Eagle's medium (Sigma Chemical Co, St Louis, MO) containing 10% heat-inactivated fetal calf serum, S X 2-mercaptoethanol, 100 U/mL penicillin, and 100 &mL streptomycin.
To isolate nuclei from nonadherent cell lines, cells were washed twice with chilled phosphate-buffered saline (PBS) and treated with NP-40 lysis buffer ( and finally hybridized at 65°C overnight to a "P-labeled RAG-I gene fragment (shown in Fig I ) in 6 x standard saline citrate (SSC), 0.5% SDS, 5X Denhardt's, and 100 pg/mL denatured salmon sperm DNA. Membranes were washed to a final stringency of 0.1 x SSC and 0. I % SDS at 65°C and were exposed at -70 "C for 60 hours to Fuji RX film (Fuji, Kanagawa, Japan) in the presence of Dupont Kronex Lightening Plus enhancing screen (Dupont).
To examine the RAG-1 promoter activity, -2.8 kb to +50 nt region relative to the major transcription start site, -1 IO nt to +50 nt region, -86 nt to +50 nt region, and + I 4 nt to +50 nt region of human RAG-I gene were linked to the PGV-B vector (Toyo Ink, Tokyo, Japan) that contained a promoterless firefly luciferase reporter gene, creating pRL(-2.8 kb), pRL(-1 IO), pRL(-86). and pRL(+14), respectively. For pRL(Kpn IlXho I), a DNA fragment containing 568-nt 5' upstream region of the first exon, the first exon and an intron between the first and the second exon were subcloned in PGV-P vector (Toyo Ink), which contained a luciferase reporter gene linked to the SV40 promoter in the reverse direction relative to SV40 promoter. The constructed plasmids were examined to confirm the correct construct by restriction-enzyme digestion and, in some cases, by DNA sequencing. As a positive control, PGV-C vector (Toyo Ink) containing a luciferase gene linked to SV40 enhancer and promoter sequences was used.
Logarithmically growing cells were washed twice with PBS and resuspended at a density of IO' Plasmid consrrucrions.
Transient rrunxfecrion ussu?~.
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From cellslmL in PBS. A total of 50 yg of luciferase reporter constructs together with pSRaLacZ containing 0-galactosidase reporter gene linked to the SRa promoter" was added to 500 yL of cell suspension. The mixture was then transferred to a 0.4-cm gap electroporation cuvette (BioRad. Richmond, CA). Electroporation was performed with the Gene Pulser (BioRad) at 960 pF and 300 V for Nalm6, at 250 V for Raji, and at 270 V for KS62. For Hep3B, DNA was introduced by a calcium-phosphate method as previously described." Cells were transferred to culture dishes containing 10 mL of culture medium and were incubated for 24 hours at 37°C in a humidified COz incubator. After washing twice with PBS, cells were lysed by lysing buffer, and luciferase activities in cell lysates were assessed using the PicaGene kit (Toyo Ink) and a luminometer (Bio-Orbit Oy, Turku. Finland). Transfection efficiency was normalized by measuring &galactosidase activities in the same cell lysates as described previously.'" HS2 , HS3, and HS4) were identified in a RAG-I -expressing human pre-B-cell line, Nalm6. These DNase I HS sites were detected by Southern blot hybridization analysis using other restriction enzymes and probes (data not shown). HSI, HS2, and HS3 sites were located at ~3 . 5 kb, ~0 . 8 kb, and ~0 . 1 kb upstream of the major transcriptional initiation site of the human RAG-I gene, respectively (Fig 2) , whereas the HS4 site was present HS1 at = 1.7 kb downstream of the first exon. The HSl site was also found in a RAG-1-mature B-cell line, RPMI-1788, and in a RAG-I-hepatoma cell line, Hep3B, showing that the existence of HS 1 site is ubiquitous. On the other hand, HS2, HS3, and HS4 sites were not detected in RAG-1-RPMI-1788 or Hep3B (Fig l) , showing that the existence of these HS2, HS3, and HS4 sites is in accordance with the expression of RAG-1. To confirm the above observation, DNase I HS sites were examined in other cell lines: RAG-1 -B-cell line (Raji), RAG-1' T-cell line (Jurkat and CEM), RAG-1-T-cell line (HUl78), and RAG-1-nonlymphoid cell lines (K562, U937 and HeLa). As summarized in Fig 2, all HSl, HS2, HS3, and HS4 sites were present in Jurkat and CEM. In Raji, HUl78, U937, K562, and HeLa, only the HSI site was present, and the HS2, HS3, and HS4 sites were absent. These data confirm the significant differences in the chromatin structure of RAG-1 gene in RAG-1' and RAG-1-lymphoid or nonlymphoid cells. The presence of DNase I HS sites 2 to 4 in the cells expressing RAG-I suggests that these regions may contribute to the specific regulation of RAG-1 expression. Effect of DNA segments containing DNase I HS sites on transcriptional activities. We then examined whether DNA segments containing the HS2 or HS3 sites show any effects on transcriptional activities in transient expression assays. We constructed luciferase reporter genes linked to the various portions of the RAG-I upstream sequences that contained or did not contain HS2 or HS3 sites (Fig 3A) . HS2 and HS3 sites were located at ~0 . 8 kb and -0.1 kb upstream of the major transcriptional initiation site, respectively (Kurioka et al, unpublished data). pRL(-2.8 kb) yielded approxi- Relative Luciferase activity ( fold ) mately fourfold luciferase activity above pRL(+ 14) that did not contain the major transcriptional initiation site. Deletion of upstream sequences from -2.8 kb to -1 10 nt still yielded the same level of promoter activity, showing that DNA region around HS2 site has little, if any, enhancing or suppressing effect on the RAG-I promoter activity. Further deletion of upstream sequences down to -86 nt remarkably reduced the promoter activity to the similar level of pRL(+14). The result showed that the HS3 site was located at the promoter region that contains a DNA fragment indispensable for the promoter activity. Then, we examined whether the HS3 or HS4 sites show any enhancing effects on RAG-I promoter activity. A 5.8-kbp Xho IIKpn I fragment spanning from -568 nt upstream of the transcription initiation site to the first nt of the second exon was linked to a luciferase reporter gene, PGV-P. in reverse orientation relative to the SV40 promoter [pRL(Kpn I I X h I); see Fig 4A] . pRL(Kpn IIXho 1) was transfected into Nalm6 cells, and the luciferase activity was compared with those of PGV-P as well as PGV-C; the latter contained both SV40 promoter and SV40 enhancer ( Fig 4A) . As shown in Fig 4B, although SV40 enhancer sequence augments the transcriptional activity of SV40 promoter, the Xho IIKpn 1 fragment that contained HS3 and HS4 sites did not enhance the transcriptional activity.
RES U LTS
-110 to -86 nt region itself does not confer cell-or stage-specific expression in transient expression asso!. To determine whether the RAG-I promoter sequences themselves confer cell-and/or stage-specific expression, we performed comparative transient expression assays in the RAG-I -expressing Nalm6, as well as RAG-I -nonexpressing Raji, KS62, and Hep3B. Table 1 shows that pRL(-110) yielded threefold to fourfold luciferase activity compared with that of pRL(-86) not only in R A G I ' cells but also in RAG-I -cells. These data show that the -I I O to -86 nt region itself is not sufficient, at least in this transient expression assay, to regulate the differential RAG-I expression between the RAG-I + and RAG-1 -cells.
DISCUSSION
Although RAG-1 and RAG-2 genes were concomitantly expressed in a tissue-or stage-specific mannery.'.'.' the regulation of their expression is poorly understood. In the present study, we have examined chromatin structure of human RAG-I gene by analyzing DNase I HS sites in the vicinity of the promoter region and a part of the intron.
It was reported that DNase I HS sites involve a DNA region that regulates transcription of genes, such as promoter, enhancer, silencer, and local control region^.'^^'" Recently, DNase I HS sites of murine CD4 gene present in T cells was shown to associate with enhancer activity and silencer activity that regulate cell-and differentiation stagespecific expression of murine CD4."-'" It was also shown that the 5' flanking region within a DNase I HS site mediates In the current study, we showed that at least four DNase I HS sites (HS I , HS2, HS3, and HS4) were detected in RAG-I -expressing lymphoid cells, and three of them (HS2, HS3 and HS4) were associated with RAG-I expression (Figs I and 2). Among these HS sites, the HS3 site was located at the RAG-I promoter region (Fig 3) . and a DNA fragment (-1 10 to -86) within this HS3 site was found to be indispensable for the promoter activity. These data are in accordance with those of Shanberg et al," who showed that human CD7 gene has a TATA-less promoter. and that one of the DNase I HS sites existed in the promoter region of the CD7 gene only in CD7-expressing cells.
An intriguing finding was that, when this DNA fragment was introduced into various cell lines, it functioned as a promoter not only in RAG-I-expressing cells but also in RAG-I -nonexpressing cells ( Table I ). The result implies that this promoter region itself does not confer the specificity of RAG-I expression. Similar results were obtained by He et al. " Their results showed that the human CD34 promoter sequences located within a DNase I HS site, which was found specifically in CD34-expressing cells, did not confer tissue-or stage-specific expression in transient expression assays. These results, together with our results, indicate that opening of the chromatin structure in the promoter region and accessibility to appropriate transcriptional factors might be prerequisite for the specific transcriptional regulation of RAG-I gene.
In Figs 3 and 4, using DNA segments containing HS2, HS3, or HS4 sites linked to the luciferase reporter gene, we showed that HS2, HS3, and HS4 sites had no enhancing effects on RAG-1 promoter activity in transient expression assays. It is likely that the lack of enhancer activity in the region could be due to the lack of cooperation with SV40 promoter. With this regard, it has been shown that transcriptional activators, Oct-l and Oct-2, direct activation of an snRNA promoter and an mRNA promoter, respectively, but not vice versa." The alternative possibility is that, in fact, these sites show regulatory effects on RAG-1 expression in vivo but not in vitro. It was shown that three of four human ,&globin gene local control region sequences conferred position-independent and copy number-dependent expression of linked genes only when introduced into the germline of transgenic m i~e .~~.~' Diaz et a13* also reported that, although a DNA fragment containing T-cell-specific DNase I HS sites at the 3' end of the TCRa/G locus did not function as an enhancer in transient expression assays, it did induce high-level expression of a linked TCRa gene in transgenic mice. Similarly, Lang et a139 showed that genomic sequences at the 3' flanking region of the human CD2 gene conferred high-level, tissue-specific, position-independent expression of the gene when introduced into the germline of mice. Thus, it is important to investigate the in vivo regulatory effects of HS2, HS3, and HS4 sites on RAG-1 transcription using a transgenic mice system. Because the promoter activity of the 5' upstream region of RAG-1 was only about fivefold above that of initiation site-less control [pRL( + 14)] in RAG-1 -expressing Nalm6 cells, other regulatory element@) outside of the RAG-1 promoter region could be necessary for proper activation of RAG-1 promoter. With this regard, RAG-2 gene exists on the same chromosome and is located 3' downstream of RAG-1 gene,4o and its expression is coordinated with RAG-1 expre~sion.~,~,'.'~ It is assumed that common regulatory element(s) may control the expression of these two genes. Thus, it is likely that appropriate regulation of RAG-1 and RAG-2 gene expression is provided by additional cell-or differentiation stage-specific enhancer or silencer sequences existing outside of the RAG-1 promoter region. 
